Evoke Pharma to Report Third Quarter Results on November 9, 2022

November 2, 2022

https://www.globenewswire.com/news-release/2022/11/02/2546539/28255/en/Evoke-Pharma-to-Report-Third-Quarter-Results-on-November-9-2022.html

SOLANA BEACH, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the Company is scheduled to release its third quarter on Wednesday, November 9, 2022, after the market closes.

Read more at globenewswire.com

Related news for (EVOK)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.